Cargando…
Chiral discrimination of cyclodecapeptide to anti-COVID-19 clinical candidates: a theoretical study
Various undesirable side effects are frequently associated with isomers of chiral clinical agents. The separation of chiral medicines remains a challenging issue in the medicines research. In this work, we employed cyclic decapeptide as the host molecule and the M06-2X theoretical computational meth...
Autores principales: | Yang, Jian, Wang, Xinqing, Ji, Shuangshuang, Zhu, Yanyan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10011793/ https://www.ncbi.nlm.nih.gov/pubmed/37363041 http://dx.doi.org/10.1007/s11224-023-02149-5 |
Ejemplares similares
-
Antiplasmodial Cyclodecapeptides from Tyrothricin Share a Target with Chloroquine
por: Leussa, Adrienne N.-N., et al.
Publicado: (2022) -
(18)F-labeled Dimer-Sansalvamide A Cyclodecapeptide: A Novel Diagnostic Probe to Discriminate Pancreatic Cancer from Inflammation in a Nude Mice Model
por: Wang, Xiaohui, et al.
Publicado: (2022) -
Chiral discrimination in platinum anticancer drugs.
por: Benedetti, Michele, et al.
Publicado: (2002) -
Chiral derivatization-enabled discrimination and on-tissue detection of proteinogenic amino acids by ion mobility mass spectrometry
por: Xie, Chengyi, et al.
Publicado: (2022) -
Discrimination of cryptochirality in chiral isotactic polystyrene by asymmetric autocatalysis
por: Kawasaki, Tsuneomi, et al.
Publicado: (2009)